Ahmad Sadr
Corporate Officer/Principal presso APELLIS PHARMACEUTICALS, INC.
Posizioni attive di Ahmad Sadr
Società | Posizione | Inizio | Fine |
---|---|---|---|
APELLIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Direttore Tecnico/Scientifico/R&S | 01/01/2017 | - |
Storia della carriera di Ahmad Sadr
Precedenti posizioni note di Ahmad Sadr
Società | Posizione | Inizio | Fine |
---|---|---|---|
PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2016 | 01/01/2017 |
Vision Medicines, Inc.
Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Direttore Tecnico/Scientifico/R&S | 01/04/2015 | 01/05/2016 |
Formazione di Ahmad Sadr
Widener University | Graduate Degree |
University of Maryland | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Posizioni
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Graduate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
APELLIS PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Vision Medicines, Inc.
Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Health Technology |
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Ahmad Sadr
- Esperienza